Medication info
Mahakan Tablet 8/5 mg

Mahakan Tablet 8/5 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Pink, double convex, round film-coated tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201603935 · Approved 2016.06.24 · Insurance code 640007030

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose of each individual component (candesartan cilexetil or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. -8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or this medicine 16/5 mg. Patients taking candesartan cilexetil and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. • Patients with renal impairment: Since an initial dose of candesartan cilexetil of 4 mg once daily is recommended for patients with renal impairment, it is not advisable to use this medicine as initial treatment. • Patients with hepatic impairment: Since an initial dose of candesartan cilexetil of 2 mg once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this medicine as initial treatment.
Child dose
Adolescents and children aged 18 years or younger: Use of this medicine is not recommended.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Essential hypertension is used when blood pressure is not adequately controlled with Candesartan Cilexetil or Amlodipine monotherapy. In this case, the combination of these two medications helps effectively lower and manage blood pressure. This can reduce the risk of cardiovascular complications caused by hypertension. Therefore, this medication is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose of each individual component (candesartan cilexetil or amlodipine) be adjusted before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. -8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or this medicine 16/5 mg. Patients taking candesartan cilexetil and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. • Patients with renal impairment: Since an initial dose of candesartan cilexetil of 4 mg once daily is recommended for patients with renal impairment, it is not advisable to use this medicine as initial treatment. • Patients with hepatic impairment: Since an initial dose of candesartan cilexetil of 2 mg once daily is recommended for patients with mild or moderate hepatic impairment, it is not advisable to use this medicine as initial treatment.

Child dose

Adolescents and children aged 18 years or younger: Use of this medicine is not recommended.

Precautions

This medicine can cause serious harm to the fetus during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Persons allergic to this drug or similar ingredients, pregnant or breastfeeding women, patients with severely impaired liver or kidney function, and patients with certain diseases should not use this medication. Elderly patients or those with very low blood pressure, patients with slightly impaired liver or kidney function, and patients with heart disease should use this medication with caution. Side effects such as dizziness, headache, indigestion, swelling, and itching may occur during treatment, so any abnormal symptoms should be discussed with a doctor or pharmacist. It is especially important to have regular blood pressure and blood tests due to the risk of excessively low blood pressure or worsening kidney function. Interactions may occur when taken with other antihypertensive drugs, certain diuretics, potassium supplements, etc., so it is essential to inform the doctor about any current medications. Caution is necessary when driving or operating machinery as dizziness or drowsiness may occur. Women who are planning to become pregnant or may be pregnant should not take this medication, and it is also advisable to avoid it while breastfeeding. The safety of this medication has not been established for children and adolescents, so it is advisable not to administer it to individuals under 18 years of age. In case of overdose, symptoms such as severe hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • Hemorrhoids
  • gastritis
  • upper abdominal pain
  • colon polyp
  • pancreatitis
  • chronic gastritis
  • gastroesophageal reflux disease
  • irritable bowel syndrome
  • reflux
  • constipation
Show 130 more
  • nausea
  • abdominal discomfort
  • dizziness
  • headache
  • head discomfort
  • anosmia
  • sensory disturbance
  • abnormal liver function tests
  • increased ALT
  • increased AST
  • elevated triglycerides
  • palpitations
  • chest discomfort
  • fatigue
  • peripheral edema
  • facial edema
  • chest pain
  • myalgia
  • arthralgia
  • mucositis
  • limb pain
  • lumbago
  • pruritus
  • rash
  • eosinophilia
  • hearing impairment
  • dry eyes
  • cystitis
  • acute sinusitis
  • pharyngitis
  • ocular contusion
  • ligament sprain
  • laceration
  • dyslipidemia
  • hypertriglyceridemia
  • dyspnea
  • cough
  • cholecystitis
  • flushing
  • increased blood pressure
  • gastrointestinal pain
  • orthostatic hypotension
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • vertigo
  • drowsiness
  • abdominal pain
  • nausea
  • myasthenia
  • fever
  • paresthesia
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • nosebleeds
  • anxiety
  • depression
  • somnolence
  • hematuria
  • paralysis
  • tension increase
  • syncope
  • facial flushing
  • facial swelling
  • thirst
  • sleep disorders
  • decreased libido
  • forgetfulness
  • poor appetite
  • increased appetite
  • tinnitus
  • taste disturbances
  • erectile dysfunction
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • bowel edema
  • diarrhea
  • increased liver enzyme levels
  • hepatitis
  • jaundice
  • urticaria
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urinary dysfunction
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • myocardial infarction
  • arrhythmia
  • chest pain
  • sinoatrial block
  • atrioventricular block
  • substernal pain
  • diarrhea
  • loose stools
  • erythematous skin lesions
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • angioedema

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pink, double convex, round film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.